News on SENES Oak Ridge%2C Inc.%2C from BioPortfolio.com http://www.BioPortfolio.com Consolidated SENES Oak Ridge%2C Inc.%2C news from BioPortfolio.com Wed, 10 Feb 2010 14:16:42 GMT en Mass spectrometer leverages R&D 100 Award-winning tech for gas analysishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038721&HITNO=0&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038721&THISHREF=http://c.moreover.com/click/here.pl%3fz2537725987%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038721&HITNO=0&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038721&THISHREF=http://c.moreover.com/click/here.pl%3fz2537725987%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Mansell Promoted to Manager, U.S. Fleet Services for Amgen USAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039613&HITNO=1&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039613&THISHREF=http://c.moreover.com/click/here.pl%3fz2538250607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039613&HITNO=1&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039613&THISHREF=http://c.moreover.com/click/here.pl%3fz2538250607%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFleet Financials: Amgen Sees Positive Data in Bone Drug Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039885&HITNO=2&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039885&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447805%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039885&HITNO=2&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039885&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447805%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: D-Mab Ascending Bone Throne: Phase III Strong in Prostate, toohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=3&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=3&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Amgen Tops Novartis at Reducing Fractures in Prostate Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040747&HITNO=4&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040747&THISHREF=http://c.moreover.com/click/here.pl%3fz2538857698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040747&HITNO=4&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040747&THISHREF=http://c.moreover.com/click/here.pl%3fz2538857698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: Gastroenterology: Researchers from Amgen, Inc. provide details of new studies and findings in the area of gastroenterologyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033360&HITNO=5&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033360&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033360&HITNO=5&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033360&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Amgen Advances Effort To Sell Bone Drug For Cancer Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037248&HITNO=6&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037248&THISHREF=http://c.moreover.com/click/here.pl%3fz2536994735%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037248&HITNO=6&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037248&THISHREF=http://c.moreover.com/click/here.pl%3fz2536994735%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMorningstar.com: Amgen Advances Effort To Sell Bone Drug For Cancer Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036873&HITNO=7&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036873&THISHREF=http://c.moreover.com/click/here.pl%3fz2536810348%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036873&HITNO=7&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036873&THISHREF=http://c.moreover.com/click/here.pl%3fz2536810348%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: Amgen Advances Effort To Sell Bone Drug For Cancer Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036863&HITNO=8&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036863&THISHREF=http://c.moreover.com/click/here.pl%3fz2536804026%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036863&HITNO=8&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036863&THISHREF=http://c.moreover.com/click/here.pl%3fz2536804026%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLloyd's: Amgen sees positive data in bone drug studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036965&HITNO=9&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036965&THISHREF=http://c.moreover.com/click/here.pl%3fz2536846772%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036965&HITNO=9&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036965&THISHREF=http://c.moreover.com/click/here.pl%3fz2536846772%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: Amgen Sees Positive Data In Bone Drug Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036895&HITNO=10&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036895&THISHREF=http://c.moreover.com/click/here.pl%3fz2536816611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036895&HITNO=10&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036895&THISHREF=http://c.moreover.com/click/here.pl%3fz2536816611%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Amgen sees positive data in bone drug studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036628&HITNO=11&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036628&THISHREF=http://c.moreover.com/click/here.pl%3fz2536689055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036628&HITNO=11&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036628&THISHREF=http://c.moreover.com/click/here.pl%3fz2536689055%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMinneapolis Star Tribune: Amgen sees positive data in bone drug studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036396&HITNO=12&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036396&THISHREF=http://c.moreover.com/click/here.pl%3fz2536599405%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036396&HITNO=12&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036396&THISHREF=http://c.moreover.com/click/here.pl%3fz2536599405%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEl Paso Times: Amgen sees positive data in bone drug studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036305&HITNO=13&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036305&THISHREF=http://c.moreover.com/click/here.pl%3fz2536565048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036305&HITNO=13&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036305&THISHREF=http://c.moreover.com/click/here.pl%3fz2536565048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Malaysia: Amgen Sees Positive Data In Bone Drug Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036180&HITNO=14&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036180&THISHREF=http://c.moreover.com/click/here.pl%3fz2536525354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036180&HITNO=14&MSIZE=349&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=SENES%20Oak%20Ridge,%20Inc.,&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036180&THISHREF=http://c.moreover.com/click/here.pl%3fz2536525354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCBS News: